Phase II Study of Sitravatinib in Combination With Tislelizumab in Patients With Advanced Biliary Tract Cancer
Clinical trial NCT04727996 · UNKNOWN
Trial details
- NCT number
- NCT04727996
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2023-07-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.